Pomerantz Law Firm Announces Class Action Lawsuit Against LifeMD, Inc.

Overview

In a significant turn of events, Pomerantz Law Firm has filed a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD), focusing on allegations of securities fraud and other malpractice by the company and certain officers. This lawsuit is particularly relevant for investors who have suffered losses during the period in question.

Details of the Lawsuit

Investors who acquired LifeMD securities during the Class Period are advised to get in touch with Pomerantz LLP, specifically with Danielle Peyton, to discuss their options and be part of the class. The deadline to apply as Lead Plaintiff is set for October 27, 2025. Those interested can find further information and the original complaint at Pomerantz Law.

In a press release dated August 5, 2025, LifeMD reported its second quarter results, which were concerning for stakeholders. CFO Marc Benathen mentioned “temporary challenges” regarding their Rex MD business, suggesting that these issues had been largely resolved. However, he also revised the company's full-year guidance for revenue and adjusted EBITDA, indicating potential implications for investors.

Impact of the Announcement

Following this press release, LifeMD's stock plummeted by 44.85%, dropping $5.31 per share to close at $6.53. This drastic devaluation has heightened investor concerns and led to actions being taken against the company by investors seeking restitution for their losses.

About Pomerantz LLP

Founded by the late Abraham L. Pomerantz, a pioneering figure in class action law, Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust litigation. The firm has a long history of representing victims of securities fraud, ensuring that their rights are upheld. With offices located in major cities globally, including New York, Chicago, and London, they have successfully recovered numerous multi-million dollar damages for their clients.

Contact Information

For those who wish to pursue this class action or require additional details, Pomerantz LLP is reaching out to affected investors through a dedicated line. Danielle Peyton can be reached at 646-581-9980 or via email at [email protected] The firm encourages potential class members to provide their postal address, phone number, and the number of shares they purchased to facilitate the process.

Conclusion

This class action lawsuit serves as a crucial reminder for investors to remain vigilant about the performance and practices of the companies they invest in. As the situation develops, all eyes will be on both LifeMD and the actions taken by Pomerantz LLP to advocate for the rights of investors. Those impacted by the company's performance are strongly encouraged to take action before the deadline approaches and to explore their options for seeking restitution.